Article List

Editorial
Meet Our Editorial Board Member
[ Vol. 21 , Issue. 23 ]
Author(s): Alexander V. Kabanov
Pages: 3273-3273 (1)
Editorial
Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)
[ Vol. 21 , Issue. 23 ]
Author(s): Benjamin Rolland and Ali Amad
Pages: 3274-3275 (2)
Sense and Sensibility When Prescribing ‘Off-Label’ to Psychiatric Patients
[ Vol. 21 , Issue. 23 ]
Author(s): David S. Baldwin, Nupur Tiwari and Robert Gordon
Pages: 3276-3279 (4)
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
[ Vol. 21 , Issue. 23 ]
Author(s): Louise Carton, Olivier Cottencin, Maryse Lapeyre-Mestre, Pierre A. Geoffroy, Jonathan Favre, Nicolas Simon, Regis Bordet and Benjamin Rolland
Pages: 3280-3297 (18)
Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety
[ Vol. 21 , Issue. 23 ]
Author(s): Vincent Laprevote, Raymund Schwan, Thomas Schwitzer, Benjamin Rolland and Johannes Thome
Pages: 3298-3305 (8)
Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder
[ Vol. 21 , Issue. 23 ]
Author(s): Pamela Sabioni, Jonathan Bertram and Bernard Le Foll
Pages: 3306-3310 (5)
Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions
[ Vol. 21 , Issue. 23 ]
Author(s): Ali Amad, Pierre Thomas and M. Mercedes Perez-Rodriguez
Pages: 3311-3316 (6)
Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness
[ Vol. 21 , Issue. 23 ]
Author(s): Youssef Kouidrat, Ali Amad and Marc De Hert
Pages: 3317-3324 (8)
Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
[ Vol. 21 , Issue. 23 ]
Author(s): Gary Hulse, Erin Kelty, Sean Hood, Amanda Norman, Maria Rita Basso and Albert Stuart Reece
Pages: 3325-3342 (18)
Off-Label Trazodone Prescription: Evidence, Benefits and Risks
[ Vol. 21 , Issue. 23 ]
Author(s): Letizia Bossini, Anna Coluccia, Ilaria Casolaro, Jim Benbow, Giovanni Amodeo, Riccardo De Giorgi and Andrea Fagiolini
Pages: 3343-3351 (9)
Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders
[ Vol. 21 , Issue. 23 ]
Author(s): Pierre Alexis Geoffroy, Bruno Etain, Jean-Arthur Micoulaud Franchi, Frank Bellivier and Philipp Ritter
Pages: 3352-3358 (7)
Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders
[ Vol. 21 , Issue. 23 ]
Author(s): Nicolas Simon, Benjamin Rolland and Laurent Karila
Pages: 3359-3366 (8)
GABA<sub>B</sub> Agonists for the Treatment of Alcohol Use Disorder
[ Vol. 21 , Issue. 23 ]
Author(s): Antonio Mirijello, Fabio Caputo, Gabriele Vassallo, Benjamin Rolland, Claudia Tarli, Antonio Gasbarrini and Giovanni Addolorato
Pages: 3367-3372 (6)
Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
[ Vol. 21 , Issue. 23 ]
Author(s): Marine Mondino, Jerome Brunelin, Ulrich Palm, Andre R. Brunoni, Emmanuel Poulet and Shirley Fecteau
Pages: 3373-3383 (11)
Current Issues in the Use of fMRI-Based Neurofeedback to Relieve Psychiatric Symptoms
[ Vol. 21 , Issue. 23 ]
Author(s): Thomas Fovet, Renaud Jardri and David Linden
Pages: 3384-3394 (11)
Gender Based Differences in Stress-induced Gastric Ulcer Formation and its Regulation by Nitric Oxide (NO): An Experimental Study
[ Vol. 21 , Issue. 23 ]
Author(s): Kavita Gulati, Ayanabha Chakraborti and Arunabha Ray
Pages: 3395-3401 (7)
MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers
[ Vol. 21 , Issue. 23 ]
Author(s): Yuri V. Bobryshev, Alexander N. Orekhov and Dmitry A. Chistiakov
Pages: 3402-3416 (15)
Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells
[ Vol. 21 , Issue. 23 ]
Author(s): Maryam Zahedifard, Fadhil Lafta Faraj, Mohammadjavad Paydar, Chung Yeng Looi, Pouya Hasandarvish, Maryam Hajrezaie, Behnam Kamalidehghan, Nazia Abdul Majid, Shaden A.M. Khalifa, Hapipah Mohd Ali, Mahmood Ameen Abdulla and Hesham R. El-Seedi
Pages: 3417-3426 (10)

Article List

Meet Our Editorial Board Member

Editorial: (Thematic Issue: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze)

Sense and Sensibility When Prescribing ‘Off-Label’ to Psychiatric Patients

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends

Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety

Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder

Borderline Personality Disorder and Oxytocin: Review of Clinical Trials and Future Directions

Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental Illness

Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System

Off-Label Trazodone Prescription: Evidence, Benefits and Risks

Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders

Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders

GABA<sub>B</sub> Agonists for the Treatment of Alcohol Use Disorder

Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions

Current Issues in the Use of fMRI-Based Neurofeedback to Relieve Psychiatric Symptoms

Gender Based Differences in Stress-induced Gastric Ulcer Formation and its Regulation by Nitric Oxide (NO): An Experimental Study

MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers

Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells